Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, Ste...

FDA Recall #D-0301-2022 — Class II — November 12, 2021

Recall #D-0301-2022 Date: November 12, 2021 Classification: Class II Status: Terminated

Product Description

Morphine Sulfate in 0.9% Sodium Chloride Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Avenue, Plattsburgh, NY, 12903, NDC 70324-427-02.

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

SterRx, LLC — Plattsburgh, NY

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

880 units

Distribution

U.S.A. Nationwide

Code Information

S21317/BZE

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated